UNH Quote, Financials, Valuation and Earnings

Centene has a net margin of 6.11% compared to UnitedHealth Group's net margin of 1.7%. UnitedHealth Group's return on equity of 14.51% beat Centene's return on equity of 11.5%.

UnitedHealth Group has a consensus price target of $636.05, signalling upside risk potential of 24.44%. On the other hand Centene has an analysts' consensus of $79.39 which suggests that it could grow by 30.34%. Given that Centene has higher upside potential than UnitedHealth Group, analysts believe Centene is more attractive than UnitedHealth Group.

UnitedHealth Group has a beta of 0.583, which suggesting that the stock is 41.67% less volatile than S&P 500. In comparison Centene has a beta of 0.457, suggesting its less volatile than the S&P 500 by 54.321%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.6%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 30.21% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $99.2B, which are larger than Centene quarterly revenues of $42B. UnitedHealth Group's net income of $6.1B is higher than Centene's net income of $713M. Notably, UnitedHealth Group's price-to-earnings ratio is 33.30x while Centene's PE ratio is 10.57x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.22x versus 0.20x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 6.11% compared to UnitedHealth Group's net margin of 2.25%. UnitedHealth Group's return on equity of 14.51% beat Elevance Health's return on equity of 15.67%.

UnitedHealth Group has a consensus price target of $636.05, signalling upside risk potential of 24.44%. On the other hand Elevance Health has an analysts' consensus of $505.44 which suggests that it could grow by 35.27%. Given that Elevance Health has higher upside potential than UnitedHealth Group, analysts believe Elevance Health is more attractive than UnitedHealth Group.

UnitedHealth Group has a beta of 0.583, which suggesting that the stock is 41.67% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.828, suggesting its less volatile than the S&P 500 by 17.228%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.6%. Elevance Health offers a yield of 1.75% to investors and pays a quarterly dividend of $1.63 per share. UnitedHealth Group pays 30.21% of its earnings as a dividend. Elevance Health pays out 23.3% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $99.2B, which are larger than Elevance Health quarterly revenues of $45.1B. UnitedHealth Group's net income of $6.1B is higher than Elevance Health's net income of $1B. Notably, UnitedHealth Group's price-to-earnings ratio is 33.30x while Elevance Health's PE ratio is 13.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.22x versus 0.50x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 6.11% compared to UnitedHealth Group's net margin of 3.15%. UnitedHealth Group's return on equity of 14.51% beat Molina Healthcare's return on equity of 25.77%.

UnitedHealth Group has a consensus price target of $636.05, signalling upside risk potential of 24.44%. On the other hand Molina Healthcare has an analysts' consensus of $360.77 which suggests that it could grow by 22.64%. Given that UnitedHealth Group has higher upside potential than Molina Healthcare, analysts believe UnitedHealth Group is more attractive than Molina Healthcare.

UnitedHealth Group has a beta of 0.583, which suggesting that the stock is 41.67% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.536, suggesting its less volatile than the S&P 500 by 46.386%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.6%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 30.21% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $99.2B, which are larger than Molina Healthcare quarterly revenues of $10.3B. UnitedHealth Group's net income of $6.1B is higher than Molina Healthcare's net income of $326M. Notably, UnitedHealth Group's price-to-earnings ratio is 33.30x while Molina Healthcare's PE ratio is 14.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.22x versus 0.44x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Oscar Health has a net margin of 6.11% compared to UnitedHealth Group's net margin of -2.25%. UnitedHealth Group's return on equity of 14.51% beat Oscar Health's return on equity of 2.86%.

UnitedHealth Group has a consensus price target of $636.05, signalling upside risk potential of 24.44%. On the other hand Oscar Health has an analysts' consensus of $19.00 which suggests that it could grow by 36.41%. Given that Oscar Health has higher upside potential than UnitedHealth Group, analysts believe Oscar Health is more attractive than UnitedHealth Group.

UnitedHealth Group has a beta of 0.583, which suggesting that the stock is 41.67% less volatile than S&P 500. In comparison Oscar Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.6%. Oscar Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 30.21% of its earnings as a dividend. Oscar Health pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $99.2B, which are larger than Oscar Health quarterly revenues of $2.4B. UnitedHealth Group's net income of $6.1B is higher than Oscar Health's net income of -$54.6M. Notably, UnitedHealth Group's price-to-earnings ratio is 33.30x while Oscar Health's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.22x versus 0.46x for Oscar Health. Usually stocks with elevated PS ratios are considered overvalued.